Atrial Fibrillation

Conducting effective patient consultations and structured medication reviews (SMRs) for non-valvular atrial fibrillation (NVAF) 

Date: 21st September 2021

Cost: Free

Virtual Workshop 20:00-21:30

This promotional educational meeting has been developed by Soar Beyond and the BMS/Pfizer Alliance and is fully funded by the BMS/Pfizer Alliance. This is intended for UK Healthcare Professionals only. Treatment options will be discussed at this meeting. Eliquis (apixaban) prescribing information can be found here.

Adverse events should be reported. Reporting forms and information can be found here, or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Bristol-Myers Squibb via [email protected] or 08007311736 (UK).

The i2i Network is delighted to launch an online workshop to support you in undertaking these reviews in patients with AF with interactive live case-studies.

In this workshop, you will hear practical advice and hear latest best practice from retired GP Dr. Nigel Rowell, one of the writers in the 2021 European Heart Rhythm Association Practical Guide to DOACs (Direct Oral Anticoagulants). You will also gain practical advice on the patient consultation and GP practice pharmacist considerations including adherence from Clare Murray, Lead General Practice Pharmacist East Belfast Federation.

Speakers

Dr Nigel Rowell

Nigel was a Practice Based Commissioning Chairman, Vice-chairman of the Tees Health Authority and a CCG board member. He was involved nationally as a Clinical Advisor to NHS Improvement and a Northern region Clinical Champion in AF, promoting AF detection and early adoption of DOACs.

Nigel was later invited onto the writing team for the European Heart Rhythm Association Practical Guide to DOACs which has just received publication for the 2021 edition. He remains active within the national GPSI Cardiology movement, and educational programmes around AF and anticoagulation in general. Nigel recently retired from NHS clinical practice but resuscitated his registration to help as medical lead for the local Covid vaccination service.

 

 

Read Bio
Clare Murray

Clare Murray works as a Lead General Practice Pharmacist in the East Belfast Federation of Family Practices. She has a particular interest in type 2 diabetes and anticoagulation. Clare is a strong advocate of the general practice pharmacist role and enhancement of the skills pharmacists working in this role can bring to the wider Primary Care Team.

Clare mentors new to role pharmacists, providing training to the MDT, in both primary and secondary care on anticoagulation and undertakes assessment of both the Foundation and Independent Prescribing courses for NICPLD and Queens University Belfast.

Read Bio

Agenda

Learning objectives:

  • To consider patient factors and counselling when choosing anticoagulation in line with national guidelines
  • Sharing best practice overcoming clinician and patients resistance when transitioning from VKA to a DOAC
  • To hear from the experts using case studies of consultations and SMRs for patients with non-valvular atrial fibrillation (NVAF) – applying the i2i Network “WHOLE” approach

Supported by

sponsor

This promotional educational meeting has been developed by Soar Beyond and the BMS/Pfizer Alliance and is fully funded by the BMS/Pfizer Alliance. This is intended for UK Healthcare Professionals only. Treatment options will be discussed at this meeting. Eliquis (apixaban) prescribing information can be found here.

Adverse events should be reported. Reporting forms and information can be found here, or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Bristol-Myers Squibb via [email protected] or 08007311736 (UK).

Job bag : CV-GB-2100273

Date of Preparation July 2021

This workshop is no longer available.

Health Care Professionals Attend An Event

Book onto an event as a healthcare professional
  • All communication will be received through this email.
  • This field is for validation purposes and should be left unchanged.